MY : Analysis & Opinions

  • Showing 1-100 of 158 items
  • 1
  • 2
  • >>
  1. Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day

    December 18, 2014
    Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
  2. Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst ...

    December 18, 2014
    Pfizer (PFE) has moved its experimental Duchenne muscular dystrophy treatment into a phase II study.
  3. Myriad Genetics, Inc. (MYGN): New Analyst Report from Zacks Equity ...

    December 18, 2014
    Myriad reported a disappointing first quarter fiscal 2015 with earnings per share of $0.25 that missed the Zacks Consensus ...
  4. Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst ...

    December 17, 2014
    Developer of genomic-based clinical laboratory services, Genomic Health Inc. (GHDX) recently announced positive feedback ...
  5. Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst ...

    December 16, 2014
    Actavis plc (ACT) announced its decision to file an emergency appeal for an immediate overturn of the lower court ruling ...
  6. Harmony Gold's (HMY) Golpu Project Moves to Feasibility - Analyst ...

    December 16, 2014
    Harmony Gold Mining Company Limited (HMY) announced that its board has approved the updated prefeasibility study of the Golpu ...
  7. Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

    November 18, 2014
    Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
  8. Online Travel & Advertising Boosted by Stronger Economy - Industry ...

    November 9, 2014
    Online Travel & Advertising Boosted by Stronger Economy - Industry Outlook
  9. A Cutting-Edge Medical Stock That's Incredibly Undervalued

    October 8, 2014
    Imagine a company that takes humanity's most dreaded diseases, predicts your probability of contracting them and recommends ...
  10. An Undervalued Medical Stock At The Forefront Of Predictive Medicine

    October 8, 2014
    Imagine a company that takes humanity's most dreaded diseases, predicts your probability of contracting them and recommends ...
  11. Gold Losing Out to the Greenback. What's in Store? - Industry ...

    September 30, 2014
    Gold Losing Out to the Greenback. What's in Store? - Industry Outlook
  12. MedTech Defies Sequestration, M&As Steal the Show - Industry ...

    August 26, 2014
    MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
  13. Bull of the Day: MakeMyTrip (MMYT) - Bull of the Day

    August 5, 2014
    Bull of the Day: MakeMyTrip (MMYT) - Bull of the Day
  14. 5 Drug Companies Profiting From Generics

    August 4, 2014
    Leading generic drug maker Teva Pharmaceutical (NYSE: TEVA) posted better-than-expected earnings last week and raised its ...
  15. Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry ...

    July 24, 2014
    Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
  16. e-Commerce Stocks on Which to Click (pt. 2) - Industry Outlook

    July 2, 2014
    e-Commerce Stocks on Which to Click (pt. 2) - Industry Outlook
  17. Hedge Funds Love These 3 Pharma Stocks

    April 14, 2014
    In 2012, the star performer among sectors was the financial sector. In 2013, it was consumer discretionary stocks. For 2 ...
  18. Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook

    March 25, 2014
    Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
  19. #PreMarket Primer: Thursday, March 6: Ukrainian Crisis Pressures ...

    March 6, 2014
    The Obama administration has come under pressure to ease regulations on US natural gas exports in light of the current situation ...
  20. e-Commerce Stock Update - March 2014 (pt. 2) - Industry Outlook

    March 6, 2014
    e-Commerce Stock Update - March 2014 (pt. 2) - Industry Outlook
  21. Steel Industry Stock Outlook - March 2014 - Industry Outlook

    February 28, 2014
    Steel Industry Stock Outlook - March 2014 - Industry Outlook
  22. Are Short Sellers Wrong About These 3 Stocks?

    February 13, 2014
    Professional short sellers often like to work alone -- at least until they've built a sizable short position in a stock. ...
  23. 13 Stock Buyback Kings: Should You Buy Them?

    February 12, 2014
    Over the past few years, I've been conducting quarterly reviews of companies that are aggressive repurchasers of their ...
  24. Gold Stock Update & Outlook - Feb 2014 - Industry Outlook

    February 11, 2014
    Gold Stock Update & Outlook - Feb 2014 - Industry Outlook
  25. How I Generated A 17.1% Yield... In Just 37 Days

    February 10, 2014
    The week after options expire is one of my favorite times of each month. That's because, as usual, it means it's ...
  26. This Biotech Stock Gained 350%. Here's Why There's Still 86% ...

    February 10, 2014
    What a way to start 2014! Gloom and doom have struck the stock market with a roughly 1,000-point decline in the Dow Jones ...
  27. Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook

    December 3, 2013
    Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
  28. Despite the healthcare sectors recent torrid run, there’s still plenty to like about stocks in the industry.

    A Strong Prognosis For Healthcare Stocks

    November 19, 2013
    Despite the healthcare sectors recent torrid run, there’s still plenty to like about stocks in the industry. Aside from tailwinds ...
  29. With exponentially rising energy demand facing Asia’s Dragon, China has gotten serious about expanding its generation capacity of renewable sources.

    China Is Winning The Renewable Energy Crown

    November 13, 2013
    With exponentially rising energy demand facing Asia’s Dragon, China has gotten serious about expanding its generation capacity ...
  30. Mining (Gold) Update & Outlook - Oct 2013 - Industry Outlook

    October 15, 2013
    Mining (Gold) Update & Outlook - Oct 2013 - Industry Outlook
  31. Short Sellers Retreat From Gold Stocks (EGO, HMY, IAG)

    October 12, 2013
    September ended with gold back under $1,300 an ounce, and short sellers fled from the leading gold stocks between the September ...
  32. Vertex Building A Fortress In Cystic Fibrosis

    August 28, 2013
    Vertex is in the early days of what could be a $10B franchise in cystic fibrosis treatment.
  33. AstraZeneca Goes Back To The M&A Well Yet Again

    August 26, 2013
    AstraZeneca's acquisition of Amplimmune could pay big dividends in a decade.
  34. Amgen Sweetens The Bid And Secures Onyx

    August 26, 2013
    Amgen finalizes a value-additive deal for Onyx
  35. Better Margins Can't Hide Merck's Growth Challenges

    July 30, 2013
    Merck's near-term growth is looking weak, but margin improvements and an underestimated pipeline could offer upside.
  36. Valmont Upped to Outperform - Analyst Blog

    July 12, 2013
    We have upgraded Valmont Industries to Outperform.
  37. Amgen Puts Onyx Pharmaceuticals In Play

    July 2, 2013
    An unsolicited $120/share bid has sent Onyx soaring and rival bidders circling.
  38. The IEA Provides Some Bullishness News For Renewables

    June 28, 2013
    While it may be hard to swallow, but renewables are actually over taking fossil fuels when it comes to electricity generation. ...
  39. Astellas/Vical Start TransVax Phase III Study - Analyst Blog

    June 27, 2013
    Astellas Pharma and its partner Vical commenced a multinational phase III registration study of TransVax to control cytomegalovirus ...
  40. Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...

    June 26, 2013
    Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
  41. After A Good Run, Novartis Looks Fairly Valued

    June 12, 2013
    Novartis is a well-balanced, high-quality pharma with growth credentials, but also a fair valuation today.
  42. Warning: The Rebound May Be Over For Big Pharma

    June 10, 2013
    As investors were picking up the pieces after the dot-com implosion, they came across another troubled sector. A series of ...
  43. Express Rides Fashion Star To Online Success

    May 31, 2013
    Specialty retailer Express announced first quarter earnings May 30 that beat the consensus estimate. Not only that but it ...
  44. Valeant Eyes Bausch & Lomb

    May 28, 2013
    Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was ...
  45. Roche, Reloaded

    May 21, 2013
    Roche has one of the best long-term growth profiles in the Big Pharma space
  46. A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap

    May 21, 2013
    Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.
  47. After A Big Rally, Pfizer Might Need Some Rest

    May 21, 2013
    A big rally has brought Pfizer back to fair value.
  48. Adasuve Deal Is Very Good For Alexza, But What About Teva?

    May 9, 2013
    Teva's partnership with Alexza looks like an expensive gamble.
  49. Teva Still Too Cheap, But Still Too Uncertain

    May 3, 2013
    Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.
  50. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane ...
  51. Lannett Beats, Ups Guidance - Analyst Blog

    February 11, 2013
    Lannett Company, Inc. (LCI) reported second quarter fiscal 2013 earnings of 10 cents per share, above the Zacks Consensus ...
  52. Pipeline Setback for Idenix - Analyst Blog

    February 7, 2013
    Idenix Pharmaceuticals, Inc. (IDIX) recently announced that the company has decided to discontinue its clinical development ...
  53. MedTech Industry Stock Outlook - Jan 2013 - Zacks Analyst Interviews

    January 29, 2013
    We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide ...
  54. Why Smart Investors Are Pouring Trillions into This Type Of Stock

    January 18, 2013
    For decades, analysts have heralded small-cap stocks as the real growers in the stock market. And they're right to some extent; ...
  55. With Ball Corp, Quality Doesn't Come Cheap

    January 4, 2013
    Ball is a top-notch company, but the stock price reflects that.
  56. Abbott Labs Spins Off AbbVie: Which Is The Better Buy?

    January 4, 2013
    January 2 was the first day of trading for the pharmaceutical spin-off.
  57. Goldcorp Inc and Other Gold and Silver Stocks Making Big Moves ...

    January 3, 2013
    There has been little movement in the market so far this morning. The Nasdaq remains relatively unchanged; the S&P 5 ...
  58. The Absolute Highest Yields You'll Find... in 8 Major Sectors

    December 13, 2012
    Readers of my articles should know by now that I'm always on the lookout for good dividend-paying ideas. There's no better ...
  59. BMY/ABT Present Oncology Data - Analyst Blog

    December 12, 2012
    Bristol-Myers Squibb Company (BMY) and partner Abbott Laboratories (ABT) recently presented data on their oncology candidate ...
  60. Gilead Plans to Split Stock 2-for-1 - Analyst Blog

    December 11, 2012
    Recently, the board of directors at Gilead Sciences Inc. (GILD) authorized a two-for-one stock split. The action, which will ...
  61. Warner Chilcott Evenly Poised - Analyst Blog

    November 23, 2012
    We are maintaining our Neutral recommendation on Warner Chilcott plc (WCRX) with a target price of $12.00. The stock carries ...
  62. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  63. Novo Nordisk A/S and More Big Movers in Healthcare on November ...

    November 6, 2012
    The Nasdaq remains relatively unchanged, the S&P 500 has climbed 0.4% and the Dow is trading up 0.6% so far today. The ...
  64. Teva Likely To Tread Water Ahead Of New Strategy

    November 5, 2012
    Teva has restructuring and growth opportunities, but the risk is still elevated.
  65. Alcoa Is A Potential Value Call

    October 10, 2012
    Alcoa is doing the best it can in a tough market. The company probably needs aluminum prices above $1 or $1.10/lb for the ...
  66. LIFE Continues Acquisition Spree - Analyst Blog

    October 9, 2012
    Life Technologies (LIFE) is on an acquisition bandwagon, targeted towards building its diagnostics franchise. The company ...
  67. Shire Settles Patent Dispute - Analyst Blog

    September 12, 2012
    Shire LLC, a subsidiary of Shire plc (SHPG) recently announced that it has entered into a settlement agreement with Anchen ...
  68. The Week In Healthcare

    August 31, 2012
    Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer rally. ...
  69. Ball Corp to Streamline Production - Analyst Blog

    August 16, 2012
    Ball Corporation (BLL) recently announced that it will cut down 12-ounce beverage can and end production capacity by stalling ...
  70. Bull Vs. Bear - Travel Stocks Not Worth The Trip

    August 8, 2012
    The risk of competition from Google and the current economic conditions could keep investors at home when it comes to investing ...
  71. Portfolio Pruning 101

    July 27, 2012
    MoneyShow's Tom Aspray takes an in-depth look at his successful Charts in Play Portfolio, as he looks to take profits on ...
  72. Bristol-Myers Squibb's Second Quarter Earnings Report

    July 25, 2012
    Bristol-Myers Squibb Company (NYSE:BMY) announced its results for the second quarter on July 25, 2012. Bristol-Myers Squibb ...
  73. Setback for Chelsea Therapeutics - Analyst Blog

    July 6, 2012
    Chelsea Therapeutics International, Ltd. (CHTP) recently suffered a setback when the US Food and Drug Administration (FDA), ...
  74. Biggest Healthcare Sector Movers for July 3, 2012

    July 3, 2012
    The market is doing well so far today. The Nasdaq has moved up 0.7%; the S&P 500 is up 0.7%; and the Dow has risen 0.6%. ...
  75. Medicine Gets Personalized

    June 28, 2012
    With our population continuing to age and grow, innovation in the healthcare sector will need to move just as fast. One such ...
  76. Emerging Market Guru Looking Towards Africa

    June 22, 2012
    Guru Mark Mobius, the leading pundit on emerging markets, is trying to bring attention to Africa's unheralded growth story. ...
  77. Update on Amylin's Metreleptin - Analyst Blog

    June 19, 2012
    Amylin Pharmaceuticals, Inc. (AMLN) recently provided an update on its regulatory status for metreleptin. In an 8K filing ...
  78. Playing The North Sea's Windy Potential

    June 8, 2012
    With its current energy production strategy showing signs of strain, the U.K. has unveiled ambitious plans to turn the North ...
  79. Five Wind Energy Stocks To Watch

    May 28, 2012
    One shining example in the renewable energy space is the wind energy sector. Capacity continues to grow and offers a value ...
  80. A Turning Point For Japan

    May 4, 2012
    While Japan has been called dead money for years, a falling yen could finally mean the nation is turning a corner. For investors, ...
  81. Eli Lilly Paying Investors To Wait

    May 3, 2012
    The pharmaceutical giant reported decent first quarter results late in April 2012. However, It will likely be some time before ...
  82. 5 South African Stocks To Consider For 2012

    April 27, 2012
    These South African stocks have been down over the last 52 weeks, which could be a buying opportunity of the newest member ...
  83. 5 Wind Energy Stocks To Watch

    March 23, 2012
    One shining example in the renewable energy space is the wind energy sector. Capacity continues to grow and offers a value ...
  84. 15 Biotech Companies Waiting For FDA Approval

    March 21, 2012
    Despite all of these uncertainties, investors still heavily focus on whether a company's new drug will be approved by the ...
  85. Obama’s Corporate Tax Proposal: Which Companies Will Take A Hit?

    February 24, 2012
    President Obama has proposed corporate tax cuts that will lower corporate income taxes from 35% to 28%, but claims he willl ...
  86. 5 South African Stocks To Consider For 2012

    February 13, 2012
    These South African stocks have been down over the last 52 weeks, which could be a buying opportunity of the newest member ...
  87. Pfizer Shrugs Off the Loss Of Lipitor

    February 6, 2012
    Pfizer remains very profitable and has ample cushion to adjust its cost structure to maintain a respectable level of profit ...
  88. Muni's Are Still Attractive

    February 2, 2012
    Municipal bonds continue to offer value for those investors in higher tax brackets.
  89. "Dominant" Pattern Inspires 4 Buys

    February 1, 2012
    Reverse head-and-shoulders bottom formations in three stocks and an emerging market ETF are creating worthwhile buying opportunities ...
  90. Big Buys In Share Buybacks

    January 27, 2012
    Record corporate profits and super low interest rates are resulting in a shrinking market environment and a rise in share ...
  91. Four Stocks Flashing Buy Signals

    January 24, 2012
    Here are four of the most attractive stocks based on fundamentals and the charts.
  92. 5 Wind Energy Stocks To Watch

    January 18, 2012
    One shining example in the renewable energy space is the wind energy sector. Capacity continues to grow and offers a value ...
  93. Latin America Gives Wind Power A Go

    January 3, 2012
    Latin America is poised to be one of the biggest generators of wind power.
  94. 2011 In Review - Pharmaceuticals

    December 29, 2011
    2011 was a surprisingly healthy year for drug stocks.
  95. Heavy Construction Stocks To Watch In 2012

    December 22, 2011
    As more dollars are spent globally on infrastructure, the heavy construction sector could see outperformance once again. ...
  96. 5 South African Stocks To Consider For 2012

    December 22, 2011
    Some of these South African stocks have returned 50%+ over the last 52 weeks, which shows the growth potential of newest ...
  97. Finding Big Dividends In Gold

    December 5, 2011
    With gold prices remaining high, the gold mining sector could be an income seekers dream.
  98. Is Third Time The Charm For Gilead?

    November 22, 2011
    Gilead is going all in on Hep C, as it acquires Pharmasset in a massive deal.
  99. A Backdoor Into Asia's Emerging Markets

    November 8, 2011
    Japan’s recent expansion as a major exporter to Asian markets could be its saving grace.
  100. The 3 Highest Yielding Pharma Stocks

    September 30, 2011
    Learn more about three large pharmaceutical companies with the highest current yields.
  • Showing 1-100 of 158 items
  • 1
  • 2
  • >>
Trading Center